Association of promoter polymorphism -765G>C in the PTGS2 gene with malignant melanoma in Italian patients and its correlation to gene expression in dermal fibroblasts

Macarena Gomez-Lira, Silvia Ferronato, Giovanni Malerba, Mario Santinami, Andrea Maurichi, Antonella Sangalli, Alberto Turco, Paola Perego, Monica Rodolfo

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Prostaglandins, especially prostaglandin E synthetase (PGE2), influence carcinogenesis by promoting cell proliferation, inhibiting apoptosis, stimulating angiogenesis and mediating immune suppression. Cyclooxygenase-2, coded by the PTGS2 gene, is the key enzyme in the production of prostaglandins. In melanoma, Cox-2 is over expressed in primary malignant melanoma (MM) and in their corresponding metastases. Polymorphisms in the promoter region of PTGS2 gene can modulate gene expression and could modify individual susceptibility to MM. Two hundred and forty melanoma patients and 342 controls were genotyped for polymorphisms -765G>C (rs20417) and -1195A>G (rs689466). Allele -765C frequency was significantly higher in melanoma patients. No allele frequency differences for -1195A>G polymorphism were observed. Haplotype analysis revealed that the haplotypes carrying the minor alleles were associated to a higher risk of melanoma (P = 0.02). Expression analysis showed that allele -765C is associated to a higher gene expression and could represent a risk allele by affecting the functionality of the promoter.

Original languageEnglish
Pages (from-to)766-768
Number of pages3
JournalExperimental Dermatology
Volume23
Issue number10
DOIs
Publication statusPublished - Oct 1 2014

Fingerprint

Cyclooxygenase 2
Fibroblasts
Polymorphism
Gene expression
Melanoma
Genes
Gene Expression
Skin
Prostaglandins
Alleles
Cell proliferation
Ligases
Prostaglandins E
Dinoprostone
Genetic Promoter Regions
Gene Frequency
Haplotypes
Apoptosis
Enzymes
Prostaglandin-Endoperoxide Synthases

Keywords

  • Expression analysis
  • Malignant melanoma
  • Promoter polymorphisms
  • PTGS2

ASJC Scopus subject areas

  • Dermatology
  • Molecular Biology
  • Biochemistry

Cite this

Association of promoter polymorphism -765G>C in the PTGS2 gene with malignant melanoma in Italian patients and its correlation to gene expression in dermal fibroblasts. / Gomez-Lira, Macarena; Ferronato, Silvia; Malerba, Giovanni; Santinami, Mario; Maurichi, Andrea; Sangalli, Antonella; Turco, Alberto; Perego, Paola; Rodolfo, Monica.

In: Experimental Dermatology, Vol. 23, No. 10, 01.10.2014, p. 766-768.

Research output: Contribution to journalArticle

@article{179501efea884fc79cddcec6517e66c2,
title = "Association of promoter polymorphism -765G>C in the PTGS2 gene with malignant melanoma in Italian patients and its correlation to gene expression in dermal fibroblasts",
abstract = "Prostaglandins, especially prostaglandin E synthetase (PGE2), influence carcinogenesis by promoting cell proliferation, inhibiting apoptosis, stimulating angiogenesis and mediating immune suppression. Cyclooxygenase-2, coded by the PTGS2 gene, is the key enzyme in the production of prostaglandins. In melanoma, Cox-2 is over expressed in primary malignant melanoma (MM) and in their corresponding metastases. Polymorphisms in the promoter region of PTGS2 gene can modulate gene expression and could modify individual susceptibility to MM. Two hundred and forty melanoma patients and 342 controls were genotyped for polymorphisms -765G>C (rs20417) and -1195A>G (rs689466). Allele -765C frequency was significantly higher in melanoma patients. No allele frequency differences for -1195A>G polymorphism were observed. Haplotype analysis revealed that the haplotypes carrying the minor alleles were associated to a higher risk of melanoma (P = 0.02). Expression analysis showed that allele -765C is associated to a higher gene expression and could represent a risk allele by affecting the functionality of the promoter.",
keywords = "Expression analysis, Malignant melanoma, Promoter polymorphisms, PTGS2",
author = "Macarena Gomez-Lira and Silvia Ferronato and Giovanni Malerba and Mario Santinami and Andrea Maurichi and Antonella Sangalli and Alberto Turco and Paola Perego and Monica Rodolfo",
year = "2014",
month = "10",
day = "1",
doi = "10.1111/exd.12522",
language = "English",
volume = "23",
pages = "766--768",
journal = "Experimental Dermatology",
issn = "0906-6705",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Association of promoter polymorphism -765G>C in the PTGS2 gene with malignant melanoma in Italian patients and its correlation to gene expression in dermal fibroblasts

AU - Gomez-Lira, Macarena

AU - Ferronato, Silvia

AU - Malerba, Giovanni

AU - Santinami, Mario

AU - Maurichi, Andrea

AU - Sangalli, Antonella

AU - Turco, Alberto

AU - Perego, Paola

AU - Rodolfo, Monica

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Prostaglandins, especially prostaglandin E synthetase (PGE2), influence carcinogenesis by promoting cell proliferation, inhibiting apoptosis, stimulating angiogenesis and mediating immune suppression. Cyclooxygenase-2, coded by the PTGS2 gene, is the key enzyme in the production of prostaglandins. In melanoma, Cox-2 is over expressed in primary malignant melanoma (MM) and in their corresponding metastases. Polymorphisms in the promoter region of PTGS2 gene can modulate gene expression and could modify individual susceptibility to MM. Two hundred and forty melanoma patients and 342 controls were genotyped for polymorphisms -765G>C (rs20417) and -1195A>G (rs689466). Allele -765C frequency was significantly higher in melanoma patients. No allele frequency differences for -1195A>G polymorphism were observed. Haplotype analysis revealed that the haplotypes carrying the minor alleles were associated to a higher risk of melanoma (P = 0.02). Expression analysis showed that allele -765C is associated to a higher gene expression and could represent a risk allele by affecting the functionality of the promoter.

AB - Prostaglandins, especially prostaglandin E synthetase (PGE2), influence carcinogenesis by promoting cell proliferation, inhibiting apoptosis, stimulating angiogenesis and mediating immune suppression. Cyclooxygenase-2, coded by the PTGS2 gene, is the key enzyme in the production of prostaglandins. In melanoma, Cox-2 is over expressed in primary malignant melanoma (MM) and in their corresponding metastases. Polymorphisms in the promoter region of PTGS2 gene can modulate gene expression and could modify individual susceptibility to MM. Two hundred and forty melanoma patients and 342 controls were genotyped for polymorphisms -765G>C (rs20417) and -1195A>G (rs689466). Allele -765C frequency was significantly higher in melanoma patients. No allele frequency differences for -1195A>G polymorphism were observed. Haplotype analysis revealed that the haplotypes carrying the minor alleles were associated to a higher risk of melanoma (P = 0.02). Expression analysis showed that allele -765C is associated to a higher gene expression and could represent a risk allele by affecting the functionality of the promoter.

KW - Expression analysis

KW - Malignant melanoma

KW - Promoter polymorphisms

KW - PTGS2

UR - http://www.scopus.com/inward/record.url?scp=84907858460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907858460&partnerID=8YFLogxK

U2 - 10.1111/exd.12522

DO - 10.1111/exd.12522

M3 - Article

C2 - 25060715

AN - SCOPUS:84907858460

VL - 23

SP - 766

EP - 768

JO - Experimental Dermatology

JF - Experimental Dermatology

SN - 0906-6705

IS - 10

ER -